FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4248480159> ?p ?o ?g. }

• W4248480159 endingPage "A180" @default.
• W4248480159 startingPage "A179.3" @default.
• W4248480159 abstract "<h3>Introduction</h3> Rifaximin is a minimally absorbed, gut-selective antibiotic, which is safe and effective in the prevention and treatment of Hepatic Encephalopathy (HE). However, it is expensive and there is debate regarding its cost effectiveness. <h3>Aim</h3> The present study examines the impact of Rifaximin treatment on hospital admissions and hospital bed day occupancy in patients with recurrent HE, due to chronic liver disease. <h3>Methods</h3> Medical records of all 30 hospital patients with HE, commenced on Rifaximin between November 2011 and May 2013, in a District General Hospital, were evaluated. Data were collected on patient demographics, MELD scores, number of hospital admissions, bed day occupancy for each admission, and concomitant therapy for HE. We compared the clinical features and diagnoses for the number of, and length of each hospital admission for the 6 months before, and 6 months after, commencing Rifaximin treatment. <h3>Results</h3> 30 patients with HE (18 men, 12 women), median age 64 (Inter-quartile range (IQR) 51–67), were commenced on Rifaximin. 83% had Alcohol-related liver disease, 10% NASH and 7% Hepatitis C. Median MELD score was 15.5 (IQR 13.5–21). All patients were prescribed lactulose. Of the 30 patients, 5 died within 6 months of commencing Rifaximin. One patient was discontinued, due to non-compliance. 24 patients were included in the final analysis. We compared the outcomes for the 6 months prior to, and the 6 months after commencing Rifaximin treatment. Median hospital admissions were reduced from 2 admissions (IQR 1–3, Range 1–5) to 1 admission (IQR 0–2, Range 0–4, Wilcoxon p < 0.05). Median number of bed days was reduced from 27.5 (IQR 16.0–35.3, Range 2–129) to 2.5 (IQR 0–23.5, Range 0–55, Wilcoxon p < 0.05). No patient developed Clostridium difficile-associated diarrhoea in the 6 months after commencing Rifaximin. <h3>Conclusion</h3> In our hospital, the basic cost of a hospital bed day is £300. A 6 month course of Rifaximin costs £1688. This study demonstrates that Rifaximin treatment in patients with HE, due to chronic liver disease, produced a marked reduction in hospital admissions and hospital bed day occupancy in a District General Hospital, with major cost savings and improved clinical outcomes. <h3>Disclosure of Interest</h3> None Declared." @default.
• W4248480159 created "2022-05-12" @default.
• W4248480159 creator A5039160847 @default.
• W4248480159 creator A5064192929 @default.
• W4248480159 creator A5076215428 @default.
• W4248480159 creator A5081159878 @default.
• W4248480159 creator A5085026604 @default.
• W4248480159 date "2014-06-01" @default.
• W4248480159 modified "2023-09-27" @default.
• W4248480159 title "PWE-125 Rifaximin Treatment In Hepatic Encephalopathy (he) -– Marked Reduction In Hospital Admissions And Hospital Bed Day Occupancy In A District General Hospital" @default.
• W4248480159 doi "https://doi.org/10.1136/gutjnl-2014-307263.385" @default.
• W4248480159 hasPublicationYear "2014" @default.
• W4248480159 type Work @default.
• W4248480159 citedByCount "3" @default.
• W4248480159 countsByYear W42484801592017 @default.
• W4248480159 countsByYear W42484801592018 @default.
• W4248480159 crossrefType "journal-article" @default.
• W4248480159 hasAuthorship W4248480159A5039160847 @default.
• W4248480159 hasAuthorship W4248480159A5064192929 @default.
• W4248480159 hasAuthorship W4248480159A5076215428 @default.
• W4248480159 hasAuthorship W4248480159A5081159878 @default.
• W4248480159 hasAuthorship W4248480159A5085026604 @default.
• W4248480159 hasBestOaLocation W42484801591 @default.
• W4248480159 hasConcept C126322002 @default.
• W4248480159 hasConcept C141071460 @default.
• W4248480159 hasConcept C187212893 @default.
• W4248480159 hasConcept C194828623 @default.
• W4248480159 hasConcept C195910791 @default.
• W4248480159 hasConcept C2777075537 @default.
• W4248480159 hasConcept C2777214474 @default.
• W4248480159 hasConcept C2777575235 @default.
• W4248480159 hasConcept C2778889925 @default.
• W4248480159 hasConcept C2780325230 @default.
• W4248480159 hasConcept C2780732942 @default.
• W4248480159 hasConcept C501593827 @default.
• W4248480159 hasConcept C71924100 @default.
• W4248480159 hasConcept C86803240 @default.
• W4248480159 hasConcept C89423630 @default.
• W4248480159 hasConceptScore W4248480159C126322002 @default.
• W4248480159 hasConceptScore W4248480159C141071460 @default.
• W4248480159 hasConceptScore W4248480159C187212893 @default.
• W4248480159 hasConceptScore W4248480159C194828623 @default.
• W4248480159 hasConceptScore W4248480159C195910791 @default.
• W4248480159 hasConceptScore W4248480159C2777075537 @default.
• W4248480159 hasConceptScore W4248480159C2777214474 @default.
• W4248480159 hasConceptScore W4248480159C2777575235 @default.
• W4248480159 hasConceptScore W4248480159C2778889925 @default.
• W4248480159 hasConceptScore W4248480159C2780325230 @default.
• W4248480159 hasConceptScore W4248480159C2780732942 @default.
• W4248480159 hasConceptScore W4248480159C501593827 @default.
• W4248480159 hasConceptScore W4248480159C71924100 @default.
• W4248480159 hasConceptScore W4248480159C86803240 @default.
• W4248480159 hasConceptScore W4248480159C89423630 @default.
• W4248480159 hasIssue "Suppl 1" @default.
• W4248480159 hasLocation W42484801591 @default.
• W4248480159 hasLocation W42484801592 @default.
• W4248480159 hasOpenAccess W4248480159 @default.
• W4248480159 hasPrimaryLocation W42484801591 @default.
• W4248480159 hasRelatedWork W1831764779 @default.
• W4248480159 hasRelatedWork W2343375817 @default.
• W4248480159 hasRelatedWork W2751842630 @default.
• W4248480159 hasRelatedWork W2791079921 @default.
• W4248480159 hasRelatedWork W2915032079 @default.
• W4248480159 hasRelatedWork W2955589164 @default.
• W4248480159 hasRelatedWork W3127257865 @default.
• W4248480159 hasRelatedWork W4214697251 @default.
• W4248480159 hasRelatedWork W4241477215 @default.
• W4248480159 hasRelatedWork W4308769981 @default.
• W4248480159 hasVolume "63" @default.
• W4248480159 isParatext "false" @default.
• W4248480159 isRetracted "false" @default.
• W4248480159 workType "article" @default.